Treatment-resistant posttraumatic stress disorder

• Case Report: Successful management of psychogenic non-epileptic seizures with intranasal esketamine
• Can ketamine and other glutamate receptor modulators be considered entactogens?
• Promoting mental health treatment initiation of veterans with PTSD using internet-based family training and telephone coaching: Protocol for a randomized controlled trial
• Impact of Medical Comorbidities on Ketamine and Esketamine Treatment Effectiveness for Posttraumatic Stress Disorder and Depression: A Clinical Outcomes Analysis from the VA San Diego Healthcare System
• Electroconvulsive Therapy, Ketamine, and Esketamine in a Patient with Major Depressive Disorder and Multiple Comorbidities: A Case Report over 10-year Treatment from Adolescence to Adulthood
• Exploring the Relationship Between Lifestyle and Post-COVID Psychiatric Symptoms: Findings from a Brazilian Cohort
• Past and Present Role of Neurosurgical Interventions in the Management of Psychiatric Disorders: A Literature Review on the Evolution of Psychosurgery
• Vagus nerve stimulation therapy for treatment-resistant PTSD

Treatment-resistant posttraumatic stress disorder (PTSD) refers to a condition in which individuals diagnosed with PTSD do not respond adequately to standard or evidence-based posttraumatic stress disorder treatments.

see Posttraumatic stress disorder in Neurosurgery